(Q30692710)

English

The effect of ritonavir on saquinavir plasma concentration is independent of ritonavir dosage: combined analysis of pharmacokinetic data from 97 subjects

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

The effect of ritonavir on saquinavir plasma concentration is independent of ritonavir dosage: combined analysis of pharmacokinetic data from 97 subjects (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

pharmacokinetics

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Kilby JM

1

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

Hill A

2

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

Buss N

3

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 April 2002

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

97-104

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

Activity of the soft gelatin formulation of saquinavir in combination therapy in antiretroviral-naive patients. NV15355 Study Team.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2002.00090.X

21 January 2018

Relationships between exposure to saquinavir monotherapy and antiviral response in HIV-positive patients.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2002.00090.X

21 January 2018

The effect of high-dose saquinavir on viral load and CD4+ T-cell counts in HIV-infected patients.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2002.00090.X

21 January 2018

Differential inhibition of cytochrome P450 isoforms by the protease inhibitors, ritonavir, saquinavir and indinavir

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2002.00090.X

21 January 2018

Saquinavir pharmacokinetics alone and in combination with ritonavir in HIV-infected patients

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2002.00090.X

21 January 2018

Pharmacokinetic interactions between two human immunodeficiency virus protease inhibitors, ritonavir and saquinavir

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2002.00090.X

21 January 2018

Overlapping substrate specificities and tissue distribution of cytochrome P450 3A and P-glycoprotein: implications for drug delivery and activity in cancer chemotherapy.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2002.00090.X

21 January 2018

Safety and pharmacokinetics of once-daily regimens of soft-gel capsule saquinavir plus minidose ritonavir in human immunodeficiency virus-negative adults

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2002.00090.X

21 January 2018

Ritonavir and saquinavir combination therapy for the treatment of HIV infection

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2002.00090.X

21 January 2018

Saquinavir and ritonavir pharmacokinetics following combined ritonavir and saquinavir (soft gelatin capsules) administration

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2002.00090.X

21 January 2018

Discontinuation rates for protease inhibitor regimens containing ritonavir 600 mg versus ritonavir 400 mg plus saquinavir 400 mg.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2002.00090.X

21 January 2018

Phenotypic resistance to protease inhibitors in patients who fail on highly active antiretroviral therapy predicts the outcome at 48 weeks of a five-drug combination including ritonavir, saquinavir and efavirenz.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2002.00090.X

21 January 2018

Saquinavir soft-gel capsule: an updated review of its use in the management of HIV infection

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2002.00090.X

21 January 2018

Identifiers

10.1046/J.1468-1293.2002.00090.X

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

release_7ckapp2karfqpmapwrdspj7tpu

1 reference

https://api.fatcat.wiki/v0/release/7ckapp2karfqpmapwrdspj7tpu

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30692710&oldid=1980869787"